94 related articles for article (PubMed ID: 21928417)
1. Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.
Affolter A; Fruth K; Brochhausen C; Schmidtmann I; Mann WJ; Brieger J
Head Neck; 2011 Oct; 33(10):1448-57. PubMed ID: 21928417
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response.
Drigotas M; Affolter A; Mann WJ; Brieger J
J Oral Pathol Med; 2013 Sep; 42(8):612-9. PubMed ID: 23480207
[TBL] [Abstract][Full Text] [Related]
4. Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Hehlgans S; Eke I; Cordes N
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e669-76. PubMed ID: 22483702
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
6. Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer.
Affolter A; Drigotas M; Fruth K; Schmidtmann I; Brochhausen C; Mann WJ; Brieger J
Head Neck; 2013 Feb; 35(2):220-8. PubMed ID: 22302684
[TBL] [Abstract][Full Text] [Related]
7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
9. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
Slomiany MG; Black LA; Kibbey MM; Day TA; Rosenzweig SA
Biochem Biophys Res Commun; 2006 Apr; 342(3):851-8. PubMed ID: 16499871
[TBL] [Abstract][Full Text] [Related]
10. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.
Lui VW; Thomas SM; Zhang Q; Wentzel AL; Siegfried JM; Li JY; Grandis JR
Oncogene; 2003 Sep; 22(40):6183-93. PubMed ID: 13679857
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
15. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment.
Affolter A; Schmidtmann I; Mann WJ; Brieger J
Oncol Rep; 2013 Feb; 29(2):785-90. PubMed ID: 23232940
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
Ahmed KM; Dong S; Fan M; Li JJ
Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
[TBL] [Abstract][Full Text] [Related]
19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]